PROTARA THERAPEUTICS, INC. (TARA)
Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting
Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting
TFI International communique ses résultats du premier trimestre 2026
Snail Games USA Expands Publishing Portfolio with the Launch of Above The Snow
Cardlytics Announces Timing of Its First Quarter 2026 Earnings Release
Flowserve to Participate in Upcoming Investor Conferences
Public Storage Reports First Quarter 2026 Results
Logitech Appoints Robin Piispanen as Global Head of Logitech G
WEBTOON Entertainment Inc. to Report First Quarter 2026 Financial Results on May 11, 2026
Amkor Technology Reports Financial Results for the First Quarter 2026
BRIXMOR PROPERTY GROUP INCREASES 2026 OUTLOOK DRIVEN BY STRONG FIRST QUARTER OPERATING RESULTS AND ACCELERATING BUSINESS MOMENTUM